☆ 4.5 Letter

Author's Reply to Pestana et al. Comment on: Is There a Role for Therapeutic Drug Monitoring in Patients with Hidradenitis Suppurativa on Tumor Necrosis Factor-α Inhibitors?

AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2022)

Comment on: Is There a Role for Therapeutic Drug Monitoring in Patients with Hidradenitis Suppurativa on Tumor Necrosis Factor-α Inhibitors?

Mafalda Pestana et al.

AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2022)

添加到收藏夹

Article Dermatology

Dermal tunnels influence time to clinical response and family history influences time to loss of clinical response in patients with hidradenitis suppurativa treated with adalimumab

J. W. Frew et al.

Summary: The presence of dermal tunnels significantly influences the odds of achieving HiSCR and the time to achieve HiSCR, while family history influences time to loss of HiSCR.

CLINICAL AND EXPERIMENTAL DERMATOLOGY (2021)

添加到收藏夹

Article Dermatology

Therapeutic Drug Monitoring in Patients with Suboptimal Response to Adalimumab for Hidradenitis Suppurativa: A Retrospective Case Series

Tasnim Abdalla et al.

Summary: This study examined serum adalimumab concentrations and anti-adalimumab antibody status in 38 patients with moderate-to-severe hidradenitis suppurativa who had suboptimal response to adalimumab therapy. The results showed that patients with anti-adalimumab antibodies had significantly lower adalimumab levels, suggesting that therapeutic drug monitoring may help identify reasons for suboptimal response and guide dose optimization strategies.

AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2021)

添加到收藏夹

Article Gastroenterology & Hepatology

Higher Postinduction Infliximab Concentrations Are Associated With Improved Clinical Outcomes in Fistulizing Crohn's Disease: An ACCENT-II Post Hoc Analysis

Konstantinos Papamichael et al.

Summary: This study found that higher post-induction infliximab concentrations are associated with early and long-term favorable therapeutic outcomes in patients with fistulizing Crohn's disease.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2021)

添加到收藏夹

Article Dermatology

Long-term adalimumab efficacy in patients with moderate-to-severe hidradenitis suppurativa/acne inversa: 3-year results of a phase 3 open-label extension study

Christos C. Zouboulis et al.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2019)

添加到收藏夹

Article Gastroenterology & Hepatology

British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults

Christopher Andrew Lamb et al.

GUT (2019)

添加到收藏夹

Author's Reply to Pestana et al. Comment on: Is There a Role for Therapeutic Drug Monitoring in Patients with Hidradenitis Suppurativa on Tumor Necrosis Factor-α Inhibitors?

相关参考文献

Comment on: Is There a Role for Therapeutic Drug Monitoring in Patients with Hidradenitis Suppurativa on Tumor Necrosis Factor-α Inhibitors?

Dermal tunnels influence time to clinical response and family history influences time to loss of clinical response in patients with hidradenitis suppurativa treated with adalimumab

Therapeutic Drug Monitoring in Patients with Suboptimal Response to Adalimumab for Hidradenitis Suppurativa: A Retrospective Case Series

Higher Postinduction Infliximab Concentrations Are Associated With Improved Clinical Outcomes in Fistulizing Crohn's Disease: An ACCENT-II Post Hoc Analysis

Long-term adalimumab efficacy in patients with moderate-to-severe hidradenitis suppurativa/acne inversa: 3-year results of a phase 3 open-label extension study

British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults

导出引文

分享论文